Salt consumption has been extensively studied for its role in human physiology and impact on human health. Chronic, high intake of dietary salt consumption is associated with hypertension and cardiovascular disease, in addition to other adverse health outcomes. Major health and scientific organizations, such as the World Health Organization, US Centers for Disease Control and Prevention, and American Heart Association, have established high salt consumption as a major risk factor for cardiovascular diseases and stroke. Common edible salt is composed of sodium chloride.
The human body has evolved to balance salt intake with need through means such as the renin–angiotensin system. In humans, salt has important biological functions. Relevant to risk of cardiovascular disease, salt is highly involved with the maintenance of body fluid volume, including osmotic balance in the blood, extracellular and intracellular fluids, and resting membrane potential.
The well known effect of sodium on blood pressure can be explained by comparing blood to a solution with its salinity changed by ingested salt. Artery walls are analogous to a selectively permeable membrane, and they allow solutes, including sodium and chloride, to pass through (or not), depending on osmosis.
Circulating water and solutes in the body maintain blood pressure in the blood, as well as other functions such as regulation of body temperature. When salt is ingested, it is dissolved in the blood as two separate ions – Na+ and Cl−. The water potential in blood will decrease due to the increase solutes, and blood osmotic pressure will increase. While the kidney reacts to excrete excess sodium and chloride in the body, water retention causes blood pressure to increase.
The DASH-Sodium study was a sequel to the original DASH (Dietary Approaches to Stop Hypertension) study. Both studies were designed and conducted by the National Heart, Lung, and Blood Institute in the United States, each involving a large, randomized sample. While the original study was designed to test the effects of several varying nutrients on blood pressure, DASH-Sodium varies only in salt content in the diet.
Participants were pre-hypertensive or at stage 1 hypertension, and either ate a DASH-Diet or a diet reflecting an "average American Diet". During the intervention phase, participants ate their assigned diets containing three distinct levels of sodium in random order. Their blood pressure is monitored during the control period, and at all three intervention phases.
The study concluded that the effect of a reduced dietary sodium intake alone on blood pressure is substantial, and that the largest decrease in blood pressure occurred in those eating the DASH eating plan at the lowest sodium level (1,500 milligrams per day). However, this study is especially significant because participants in both the control and DASH diet group showed lowered blood pressure with decreased sodium alone.
In agreement with studies regarding salt sensitivity, participants of African descent showed high reductions in blood pressure. See sodium sensitivity below.
In 2018, the American Heart Association published an advisory stating that "if the U.S. population dropped its sodium intake to 1,500 mg/day, overall blood pressure could decrease by 25.6%, with an estimated $26.2 billion in health care savings. Another estimate projected that achieving this goal would reduce cardiovascular disease deaths by anywhere from 500,000 to nearly 1.2 million over the next decade." There has been evidence from epidemiological studies, human and animal intervention experiments supporting the links between high rate of salt intake and hypertension. A Cochrane review and meta-analysis of clinical trials showed that reduced sodium intake reduces blood pressure in hypertensive and normotensive subjects. Since controlling hypertension is related to a reduced risk of cardiovascular disease, it is plausible that salt consumption is a risk factor for cardiovascular health. However, to properly study the effects of sodium intake levels on risk of development of cardiovascular disease, long-term studies of large groups using both dietary and biochemical measures are necessary.
As of 2019, major government research organizations, such as the US Centers for Disease Control and Prevention and the European Food Safety Authority, advise consumers to reduce their consumption of salt to lower the risk of cardiovascular diseases. One 2016 review found that five studies were supportive of the evidence that reduced sodium intake lowers cardiovascular disease incidence and mortality, three contradicted this evidence, and two found insufficient evidence to reach a conclusion. The survey found 27 primary studies and 106 letters in academic journals in support of the salt evidence, 34 primary studies and 51 letters contradicting the evidence, and 7 primary studies and 19 letters that were inconclusive. There are several long-term studies which found that groups with sodium-reduced diets have lower incidences of cardiovascular disease in all demographics.
Some researchers cast doubts on the link between lowering sodium intake and the health of a given population.
Government regulatory agencies and clinical organizations, the European Food Safety Authority, the US Centers for Disease Control, and the American Heart Association recommend that consumers use less salt in their diets, mainly to reduce the risk of high blood pressure and associated cardiovascular diseases in adults and children. The World Health Organization issued a 2016 fact sheet to encourage reducing global salt consumption by 30% through 2025.
In 2015, the United States Centers for Disease Control and Prevention began an initiative encouraging Americans to reduce their consumption of salty foods. The American Heart Association defined a daily sodium consumption limit of 1500 milligrams (contained in less than 0.75 teaspoon of table salt).
According to a 2012 Health Canada report, Canadians in all age groups are consuming 3400 mg per day of sodium, more than twice as much as needed. The US Centers for Disease Control and Prevention stated that the average daily sodium intake for Americans over 2 years of age is 3436 milligrams. The majority of sodium consumed by North Americans is from processed and restaurant foods, while only a small portion is added during cooking or at the table.
In the European Union, half of the member states legislated change in the form of taxation, mandatory nutrition labeling, and regulated nutrition and health claims to address overconsumption of sodium in response to a 2012 EU Salt Reduction Framework.
A diet high in sodium increases the risk of hypertension in people with sodium sensitivity, corresponding to an increase in health risks associated with hypertensions including cardiovascular disease.
Unfortunately, there is no universal definition of sodium sensitivity; the method to assess sodium sensitivity varies from one study to another. In most studies, sodium sensitivity is defined as the change in mean blood pressure corresponding to a decrease or increase of sodium intake. The method to assess sodium sensitivity includes the measurement of circulating fluid volume and peripheral vascular resistance. Several studies have shown a relationship between sodium sensitivity and the increase of circulating fluid volume or peripheral vascular resistance.
A number of factors have been found to be associated with sodium sensitivity. Demographic factors which affect sodium sensitivity include race, gender, and age. One study shows that the American population of African descent are significantly more salt sensitive than Caucasians. Women are found to be more sodium sensitive than men; one possible explanation is based on the fact that women have a tendency to consume more salt per unit weight, as women weigh less than men on average. Several studies have shown that the increase in age is also associated with the occurrence of sodium sensitivity.
The difference in genetic makeup and family history has a significant impact on salt sensitivity, and is being studied more with improvement on the efficiencies and techniques of genetic testing. In both hypertensive and non-hypertensive individuals, those with haptoglobin 1-1 phenotype are more likely to have sodium sensitivity than people with haptoglobin 2-1 or 2-2 phenotypes. More specifically, haptoglobin 2-2 phenotypes contribute to the characteristic of sodium-resistance in humans. Moreover, prevalence of a family history of hypertension is strongly linked with the occurrence of sodium sensitivity.
The influence of physiological factors including renal function and insulin levels on sodium sensitivity are shown in various studies. One study concludes that the effect of kidney failure on sodium sensitivity is substantial due to the contribution of decreasing the Glomerular filtration rate (GFR) in the kidney. Moreover, insulin resistance is found to be related to sodium sensitivity; however, the actual mechanism is still unknown.
Possible mechanisms by which high intakes of dietary potassium can decrease risk of hypertension and instances of cardiovascular disease have been proposed, but not extensively studied. However, studies have found a strong inverse association between long-term adequate to high rates of potassium intake and the development of cardiovascular diseases.
The recommended dietary intake of potassium is higher than that of sodium. Unfortunately, the average absolute intake of potassium of studied populations is lower than that of sodium intake. According to Statistics Canada in 2007, Canadians' potassium intake in all age groups was lower than recommended, while sodium intake greatly exceeded recommended intake in every age group.
The ratio of potassium to sodium intake may account for the large difference in the occurrence of hypertension between primitive cultures eating diets made up of mostly unprocessed foods and Western diets which tend to include highly processed foods.
The growing awareness of excessive sodium consumption in connection with hypertension and cardiovascular disease has increased the usage of salt substitutes at both a consumer and industrial level.
On a consumer level, salt substitutes, which usually substitute a portion of sodium chloride content with potassium chloride, can be used to increase the potassium to sodium consumption ratio. This change has been shown to blunt the effects of excess salt intake on hypertension and cardiovascular disease. It has also been suggested that salt substitutes can be used to provide an essential portion of daily potassium intake, and may even be more economical than prescription potassium supplements.
In the food industry, processes have been developed to create low-sodium versions of existing products. The meat industry especially have developed and fine-tuned methods to decrease salt contents in processed meats without sacrificing consumer acceptance. Research demonstrates that salt substitutes such as potassium chloride, and synergistic compounds such as phosphates, can be used to decrease salt content in meat products.
There have been concerns with certain populations' use of potassium chloride as a substitute for salt as high potassium loads are dangerous for groups with diabetes, renal diseases, or heart failure. The use of salts with minerals such as natural salts have also been tested, but like salt substitutes partially containing potassium, mineral salts produce a bitter taste above certain levels.
The content is sourced from: https://handwiki.org/wiki/Chemistry:Salt_and_cardiovascular_disease